Inhibrx Stock Market Value
| INBX Stock | USD 14.08 0.10 0.72% |
| Symbol | Inhibrx |
Inhibrx Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inhibrx. If investors know Inhibrx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inhibrx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 119.39 | Revenue Per Share 0.117 | Quarterly Revenue Growth 2.333 | Return On Assets (0.57) | Return On Equity (20.31) |
The market value of Inhibrx is measured differently than its book value, which is the value of Inhibrx that is recorded on the company's balance sheet. Investors also form their own opinion of Inhibrx's value that differs from its market value or its book value, called intrinsic value, which is Inhibrx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inhibrx's market value can be influenced by many factors that don't directly affect Inhibrx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inhibrx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inhibrx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inhibrx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Inhibrx 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Inhibrx's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Inhibrx.
| 02/04/2023 |
| 11/25/2024 |
If you would invest 0.00 in Inhibrx on February 4, 2023 and sell it all today you would earn a total of 0.00 from holding Inhibrx or generate 0.0% return on investment in Inhibrx over 660 days. Inhibrx is related to or competes with Crinetics Pharmaceuticals, Merus BV, Lyell Immunopharma, Kronos Bio, Opthea, Mineralys Therapeutics,, and Eliem Therapeutics. Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic ca... More
Inhibrx Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Inhibrx's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Inhibrx upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.86 | |||
| Information Ratio | 0.0127 | |||
| Maximum Drawdown | 16.8 | |||
| Value At Risk | (6.11) | |||
| Potential Upside | 4.92 |
Inhibrx Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Inhibrx's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Inhibrx's standard deviation. In reality, there are many statistical measures that can use Inhibrx historical prices to predict the future Inhibrx's volatility.| Risk Adjusted Performance | 0.0491 | |||
| Jensen Alpha | 0.0835 | |||
| Total Risk Alpha | (0.34) | |||
| Sortino Ratio | 0.0141 | |||
| Treynor Ratio | 0.251 |
Inhibrx Backtested Returns
At this stage we consider Inhibrx Stock to be not too volatile. Inhibrx holds Efficiency (Sharpe) Ratio of 0.0115, which attests that the entity had a 0.0115% return per unit of risk over the last 3 months. We have found thirty technical indicators for Inhibrx, which you can use to evaluate the volatility of the firm. Please check out Inhibrx's Downside Deviation of 2.86, risk adjusted performance of 0.0491, and Market Risk Adjusted Performance of 0.261 to validate if the risk estimate we provide is consistent with the expected return of 0.036%. The company retains a Market Volatility (i.e., Beta) of 0.64, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Inhibrx's returns are expected to increase less than the market. However, during the bear market, the loss of holding Inhibrx is expected to be smaller as well. Inhibrx right now retains a risk of 3.14%. Please check out Inhibrx potential upside, and the relationship between the total risk alpha and kurtosis , to decide if Inhibrx will be following its current trending patterns.
Auto-correlation | 0.21 |
Weak predictability
Inhibrx has weak predictability. Overlapping area represents the amount of predictability between Inhibrx time series from 4th of February 2023 to 31st of December 2023 and 31st of December 2023 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Inhibrx price movement. The serial correlation of 0.21 indicates that over 21.0% of current Inhibrx price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.21 | |
| Spearman Rank Test | 0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 110.25 |
Inhibrx lagged returns against current returns
Autocorrelation, which is Inhibrx stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Inhibrx's stock expected returns. We can calculate the autocorrelation of Inhibrx returns to help us make a trade decision. For example, suppose you find that Inhibrx has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Inhibrx regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Inhibrx stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Inhibrx stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Inhibrx stock over time.
Current vs Lagged Prices |
| Timeline |
Inhibrx Lagged Returns
When evaluating Inhibrx's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Inhibrx stock have on its future price. Inhibrx autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Inhibrx autocorrelation shows the relationship between Inhibrx stock current value and its past values and can show if there is a momentum factor associated with investing in Inhibrx.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Inhibrx Stock Analysis
When running Inhibrx's price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.